282 related articles for article (PubMed ID: 16196436)
21. AUA issues a policy report on PSA monitoring. The American Urological Association.
Scott Morey S
Am Fam Physician; 2000 Aug; 62(4):883-4. PubMed ID: 10969861
[No Abstract] [Full Text] [Related]
22. The cautionary tale of PSA testing.
Hoffman RM; Zeliadt SB
Arch Intern Med; 2010 Jul; 170(14):1262-3. PubMed ID: 20660847
[No Abstract] [Full Text] [Related]
23. Should men be screened for prostate cancer?
Patel SM
N C Med J; 1999; 60(5):275-7. PubMed ID: 10495656
[No Abstract] [Full Text] [Related]
24. PSA velocity and prostate cancer detection: the absence of evidence is not the evidence of absence.
Perrin P
Eur Urol; 2006 Mar; 49(3):418-9. PubMed ID: 16459016
[No Abstract] [Full Text] [Related]
25. [Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].
Jegu J; Tretarre B; Grosclaude P; Rebillard X; Bataille V; Malavaud B; Iborra F; Salama G; Rischmann P; Villers A
Prog Urol; 2009 Jul; 19(7):487-98. PubMed ID: 19559380
[TBL] [Abstract][Full Text] [Related]
26. Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues.
Ito K
Int J Urol; 2009 Sep; 16(9):711-12. PubMed ID: 19777638
[No Abstract] [Full Text] [Related]
27. PSA: prostate-specific antigen, persisting scientific ambiguities.
Harv Mens Health Watch; 2009 Jul; 13(12):1-6. PubMed ID: 19718841
[No Abstract] [Full Text] [Related]
28. Application of prostate-specific antigen in prostate cancer.
Liang SL
MLO Med Lab Obs; 2008 Oct; 40(10):54, 56-7. PubMed ID: 18988558
[No Abstract] [Full Text] [Related]
29. [The PSA test--abomination or blessing? Longer follow up necessary to get an answer].
Aus G
Lakartidningen; 2010 Feb 17-23; 107(7):422-3. PubMed ID: 20384073
[No Abstract] [Full Text] [Related]
30. Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
Rosser CJ; Parker A
J Urol; 2005 Sep; 174(3):1154-5; author reply 1155-6. PubMed ID: 16094093
[No Abstract] [Full Text] [Related]
31. [Prostatic cancer--can unnecessary therapy be avoided? Prostate-specific antigens (PSA) kinetics can guide the management].
Malmström PU
Lakartidningen; 2006 Feb 1-7; 103(5):279. PubMed ID: 16512565
[No Abstract] [Full Text] [Related]
32. Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends.
Telesca D; Etzioni R; Gulati R
Biometrics; 2008 Mar; 64(1):10-9. PubMed ID: 17501937
[TBL] [Abstract][Full Text] [Related]
33. Prostate cancer: enthusiasm for screening.
Kaye KW
Med J Aust; 1995 May; 162(10):540-1. PubMed ID: 7539884
[No Abstract] [Full Text] [Related]
34. Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.
Belpomme D; Irigaray P
J Natl Cancer Inst; 2010 Apr; 102(7):506-7. PubMed ID: 20190186
[No Abstract] [Full Text] [Related]
35. [The prostate specific antigen: what can we learn from the American experience?].
Zhao XJ
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3313-5. PubMed ID: 16409833
[No Abstract] [Full Text] [Related]
36. [Value of prostate specific antigen in early diagnosis of prostatic cancer].
Xiao LP; Bi XJ; Li YN; Chen XQ; Zhang XF; Yu XP; Liu G; Yang MC; Song Z
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan; 27(1):107-8, 112. PubMed ID: 17259162
[TBL] [Abstract][Full Text] [Related]
37. Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial.
Määttänen L; Hakama M; Tammela TL; Ruutu M; Ala-Opas M; Juusela H; Martikainen P; Stenman UH; Auvinen A
Br J Cancer; 2007 Jan; 96(1):56-60. PubMed ID: 17213825
[TBL] [Abstract][Full Text] [Related]
38. Is an improved PSA screening test in sight?
Savage L
J Natl Cancer Inst; 2007 Oct; 99(20):1503-4. PubMed ID: 17925529
[No Abstract] [Full Text] [Related]
39. How valuable is prostate-specific antigen screening?
Handler S
Minn Med; 1996 Jun; 79(6):2. PubMed ID: 8692130
[No Abstract] [Full Text] [Related]
40. [Prostatic specific antigen: role and significance in urologic practice].
Manolović D; Pejcić T; Milović N
Srp Arh Celok Lek; 1994; 122(5-6):171-3. PubMed ID: 17977420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
